Clinical Trials Browser

Carcinoma, Carcinoma, Basal Cell

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Melanoma

Keratosis, Actinic

Keratosis, Actinic

Acromegaly, Dumping Syndrome, Melanoma, Neoplasms, Pituitary Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors, Pituitary ACTH Hypersecretion

Keratosis, Actinic

Keratosis, Actinic

Carcinoma, Basal Cell

Keratosis, Actinic

Carcinoma, Basal Cell

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Prostatic Neoplasms

Keratosis, Actinic

Keratosis, Actinic

Keratosis, Actinic

Keratosis, Actinic

Carcinoma, Renal Cell, Melanoma

Keratosis, Actinic

Keratosis, Actinic

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Keratosis, Actinic

Keratosis, Actinic

Keratosis, Actinic

Keratosis, Actinic

Keratosis, Actinic

Keratosis, Actinic

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Keratosis, Actinic

Melanoma, Psoriasis

Hypertriglyceridemia, Lymphoma, T-Cell, Cutaneous

Keratosis, Actinic

Keratosis, Actinic

Keratosis, Actinic

Skin Neoplasms

Carcinoma, Basal Cell, Facies

Skin Neoplasms

Carcinoma, Basal Cell

Photosensitivity Disorders, Keratosis, Actinic

Carcinoma, Squamous Cell, Melanoma, Seroma

Keratosis, Keratosis, Actinic

Keratosis, Actinic

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous

Brain Neoplasms, Carcinoma, Melanoma, Neoplasm Metastasis

Keratosis, Keratosis, Actinic

Clinical Trials

Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China

Keynote-593

Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%

Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses

SunDamage

Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage

Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial

OPTIVISMO-1

VAPOR-C

Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients

LEIDA

LEIDA 2

Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream

Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma

SESAME 2

Daylight-PDT With MAL for AK and Photodamaged Skin

Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma

An Open-Label Study of Zelboraf (Vemurafenib) in Patients With Braf V600 Mutation Positive Metastatic Melanoma

Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)

Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization vs Cryotherapy

Evaluate the Efficacy and Safety of Large-Scale Field-Directed Topical Therapy of Actinic Keratosis of the Chest w/Ingenol Mebutate 0.015%

Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents

Clinical Trial to Evaluate Biafine Cream Versus Standard Care in Subjects With Actinic Keratosis Post Cryotherapy

Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy According to the Laser Density for Actinic Keratosis

Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population

Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A

Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis

Can We Miss Pigmented Lesions in Psoriasis Patients?

TgBEX

Bilateral Comparison of Treatment of Facial Actinic Keratoses Using Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Incubation Times

Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses

Effects of Topical Diclofenac on Tumor Metabolism

Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients

Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)

Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

Safety and Efficacy Study of Imiquimod 5% Cream Applied 3x Per Week for 8 or 12 Weeks in Low Risk Nodular Basal Cell Carcinoma

Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head

Post-Operative Drainage Following Lymph Node Dissection

Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses

An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses

Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients

Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients

Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)

Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors

Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands